` ABNX (Abionyx Pharma SA) vs DAX Index Comparison - Alpha Spread

ABNX
vs
DAX Index

Over the past 12 months, ABNX has underperformed DAX Index, delivering a return of 4% compared to the DAX Index's 30% growth.

Stocks Performance
ABNX vs DAX Index

Loading
ABNX
DAX Index
Add Stock
www.alphaspread.com

Performance Gap
ABNX vs DAX Index

Performance Gap Between ABNX and GDAXI
HIDDEN
Show

Performance By Year
ABNX vs DAX Index

Loading
ABNX
DAX Index
Add Stock

Competitors Performance
Abionyx Pharma SA vs Peers

DAX Index
ABNX
ABBV
AMGN
GILD
VRTX
Add Stock

Abionyx Pharma SA
Glance View

Market Cap
42.3m EUR
Industry
Biotechnology

ABIONYX Pharma SA engages in the in discovery and development of novel therapies for patients without existing or effective treatments. The company is headquartered in Balma, Occitanie. The company went IPO on 2015-03-30. The Company’s product portfolio comprises Cerenis HDL and HDL enhancers that is designed to regress atherosclerotic plaque among patients at high risk of cardiovascular events, among others. Additionally, the Company has a portfolio of clinical and preclinical HDL programs. The firm is present in Labege in Midi-Pyrenees in France and in Ann Arbor in Michigan in the United States. In addition, it also operates through LYPRO Biosciences Inc.

ABNX Intrinsic Value
HIDDEN
Show
Back to Top